☆ 4.6 Article

Insights into Melanoma Clinical Practice: A Perspective for Future Research

CANCERS (2023)

Related references

Note: Only part of the references are listed.

Review Genetics & Heredity

Pitfalls in Cutaneous Melanoma Diagnosis and the Need for New Reliable Markers

Giang T. Lam et al.

Summary: Accurate diagnosis of melanoma is crucial for patient outcomes. However, subjective interpretation of histopathologic analysis and the difficulty in distinguishing melanoma from benign lesions using immunohistochemistry pose challenges. The lack of specific biomarkers further complicates accurate diagnosis.

MOLECULAR DIAGNOSIS & THERAPY (2023)

Add to Collection

Article Oncology

Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1

Jessica M. Logan et al.

Summary: A novel biomarker panel (Appl1, Sortilin and Syndecan-1) was found to be a strong independent predictor for both clinical and biochemical recurrence outcomes, with higher prediction performance than traditional grading. The study also found that biomarker-assisted assessment had better predictive performance for evaluating the risk of biochemical recurrence and clinical recurrence in patients with prostate cancer.

CANCERS (2023)

Add to Collection

Article Medicine, General & Internal

The Importance of Immunohistochemistry in the Evaluation of Tumor Depth of Primary Cutaneous Melanoma

Anca Maria Pop et al.

Summary: This study aimed to compare the efficiency of immunohistochemical markers (S-100, SOX10, Melan-A, HMB-45) with hematoxylin and eosin (HE) staining for evaluating Breslow thickness and staging in primary cutaneous melanoma (PCM). The results showed that S-100, SOX10, and Melan-A significantly increased the Breslow thickness compared to HE staining, while HMB-45 showed no significant difference. S-100 had the greatest impact on T category. In conclusion, these immunohistochemical markers performed well in evaluating melanoma invasion, especially in thin melanomas.

DIAGNOSTICS (2023)

Add to Collection

Article Dermatology

Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040

Melina Arnold et al.

Summary: Despite preventable cases, cutaneous melanoma remains the most serious skin cancer worldwide. Understanding the scale and profile of the disease is crucial to focus and strengthen global prevention efforts. The study reveals that melanoma is more frequent among males and is estimated to significantly increase by 2040 if current rates continue.

JAMA DERMATOLOGY (2022)

Add to Collection

Article Dermatology

PRAME immunohistochemistry for melanoma diagnosis: A STARD-compliant diagnostic accuracy study

Michaela K. O'Connor et al.

Summary: This study aimed to evaluate the diagnostic accuracy of PRAME in cutaneous melanoma. The results showed that the positive fraction of PRAME was significantly higher in malignant melanocytic lesions compared to benign melanocytic lesions, indicating that PRAME is an effective test for melanoma. The PRAME 4+ score (>75%) had high specificity and good interrater concordance, while the PRAME 2+ (>25%) and 3+ (>50%) had high sensitivity and specificity.

JOURNAL OF CUTANEOUS PATHOLOGY (2022)

Add to Collection

Article Pathology

Diagnostic utility of PRAME, p53 and 5-hmC immunostaining for distinguishing melanomas from naevi, neurofibromas, scars and other histological mimics

Robert Rawson et al.

Summary: This study investigated the utility of PRAME, p53, and 5-hmC immunostains for diagnosing melanocytic tumors. The study found that PRAME expression was significantly higher in melanomas compared to naevi, while 5-hmC expression was significantly lower. Combining PRAME and 5-hmC scores increased sensitivity for detecting melanoma. Strong PRAME and p53 staining were observed in high-grade desmoplastic melanomas, while low-grade desmoplastic melanomas, neurofibromas, and scars were negative. 5-hmC was not useful in distinguishing desmoplastic melanomas from neurofibromas or scars.

PATHOLOGY (2022)

Add to Collection

Article Pathology

Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer

Carmela Martini et al.

Summary: This study aims to develop biomarkers that accurately define the biology of prostate cancer and improve the interpretation of pathology for accurate grading. By examining the protein expression of key genes in the prostate cancer pathway, the utility of a biomarker panel was evaluated and found to reduce subjectivity and improve the reliability of pathology assessment.

PATHOLOGY (2022)

Add to Collection

Article

PRAME Immunohistochemistry as an Ancillary Test for the Assessment of Melanocytic Lesions

Cecilia Lezcano et al.

Surgical Pathology Clinics (2021)

Add to Collection

Review Biotechnology & Applied Microbiology

Role of Biomarkers in the Integrated Management of Melanoma

Piyu Parth Naik

Summary: Melanoma is an aggressive skin cancer and early detection is crucial. The high number of new cases reported in the US has led to increased focus on metastatic lesions and novel therapies.

DISEASE MARKERS (2021)

Add to Collection

Article Medical Laboratory Technology

Discordance in Diagnosis of Melanocytic Lesions and Its Impact on Clinical Management A Melanoma Referral Center Experience With 1521 Cases

Shira Ronen et al.

Summary: This study evaluated the discordance between histopathologic diagnoses of melanocytic lesions at referring institutions and at a tertiary referral cancer center. Major discordances were found in 20.2% of cases, with minor discordances in 48.8% of cases. Secondary histopathologic review by expert dermatopathologists is crucial for accurate diagnosis and recommendations for clinical management.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Dermatology

Rate of Immunohistochemistry Utilization in the Diagnosis of Cutaneous Melanocytic Lesions

Tony C. Chen et al.

Summary: The study investigated the rate of IHC utilization in the diagnosis of melanocytic lesions in a high-volume, government-funded, not-for-profit laboratory. It found that IHC was used more frequently in melanomas than nevi, with SOX10 being overwhelmingly the most frequently used IHC stain.

AMERICAN JOURNAL OF DERMATOPATHOLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects

Dekker C. Deacon et al.

Summary: Despite significant progress in treatment options, melanoma remains a leading cause of death due to skin cancer. Biomarkers have the potential to improve clinical decision making, but most remain unvalidated.

FRONTIERS IN MEDICINE (2021)

Add to Collection

Article Dermatology

Immunohistochemistry utilization in the diagnosis of melanoma

Matthew S. Dinehart et al.

JOURNAL OF CUTANEOUS PATHOLOGY (2020)

Add to Collection

Review Oncology

Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities

Roy Rabbie et al.

JOURNAL OF PATHOLOGY (2019)

Add to Collection

Review Oncology

A Review of Key Biological and Molecular Events Underpinning Transformation of Melanocytes to Primary and Metastatic Melanoma

Louise A. Jackett et al.

CANCERS (2019)

Add to Collection

Review Dermatology

Atypical Melanocytic Proliferations: A Review of the Literature

Courtney J. Ensslin et al.

DERMATOLOGIC SURGERY (2018)

Add to Collection

Article Dermatology

Immunostain use in the diagnosis of melanomas referred to a tertiary medical center: a 15-year retrospective review (2001-2015)

Randie H. Kim et al.

JOURNAL OF CUTANEOUS PATHOLOGY (2017)

Add to Collection

Article Medicine, General & Internal

Clinical practice guidelines for the diagnosis and management of melanoma: melanomas that lack classical clinical features

Victoria J. Mar et al.

MEDICAL JOURNAL OF AUSTRALIA (2017)

Add to Collection

Review Oncology

Immune system and melanoma biology: a balance between immunosurveillance and immune escape

Anna Passarelli et al.

ONCOTARGET (2017)

Add to Collection

Article Medicine, General & Internal

Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study

Joann G. Elmore et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Add to Collection

Article Medicine, General & Internal

Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study

Joann G. Elmore et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Add to Collection

Article Pathology

A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma

Arnaud Uguen et al.

DIAGNOSTIC PATHOLOGY (2015)

Add to Collection

Article Dermatology

Early detection of melanoma: Reviewing the ABCDEs

Hensin Tsao et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)

Add to Collection

Review Oncology

Do Not Let to Be Late: Overview of Reasons for Melanoma Delayed Diagnosis

Maksymilian Gajda et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)

Add to Collection

Article Dermatology

Diagnostic accuracy of malignant melanoma according to subtype

Matthew J. Lin et al.

AUSTRALASIAN JOURNAL OF DERMATOLOGY (2014)

Add to Collection

Review Biochemistry & Molecular Biology

Challenges and prospects for biomarker research: A current perspective from the developing world

Shabarni Gupta et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2014)

Add to Collection

Article Dermatology

Cutaneous Melanoma: Preoperative Tumor Diameter in a General Dermatology Outpatient Setting

Alexander Maley et al.

DERMATOLOGIC SURGERY (2014)

Add to Collection

Article Dermatology

Comparison of Clinicopathologic Features and Survival of Histopathologically Amelanotic and Pigmented Melanomas A Population-Based Study

Nancy E. Thomas et al.

JAMA DERMATOLOGY (2014)

Add to Collection

Article Oncology

Biomarker Discovery for Heterogeneous Diseases

Garrick Wallstrom et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)

Add to Collection

Article Oncology

Characteristics and survival of patients with invasive amelanotic melanoma in the USA

Jacqueline F. Moreau et al.

MELANOMA RESEARCH (2013)

Add to Collection

Article Dermatology

Amelanotic melanomas presenting as red skin lesions: a diagnostic challenge with potentially lethal consequences

Susannah E. McClain et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2012)

Add to Collection

Article Dermatology

Immunohistochemical Double Stains Against Ki67/MART1 and HMB45/MITF: Promising Diagnostic Tools in Melanocytic Lesions

Patricia Switten Nielsen et al.

AMERICAN JOURNAL OF DERMATOPATHOLOGY (2011)

Add to Collection

Article Dermatology

Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center

B. Aika Shoo et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)

Add to Collection

Article Dermatology

Dermoscopic evaluation of amelanotic and hypomelanotic melanoma

Scott W. Menzies et al.

ARCHIVES OF DERMATOLOGY (2008)

Add to Collection

Review Dermatology

Immunohistochemical characteristics of melanoma

Steven J. Ohsie et al.

JOURNAL OF CUTANEOUS PATHOLOGY (2008)

Add to Collection

Article Medicine, General & Internal

Diagnosing skin cancer in primary care: how do mainstream general practitioners compare with primary care skin cancer clinic doctors?

Philippa H. Youl et al.

MEDICAL JOURNAL OF AUSTRALIA (2007)

Add to Collection

Article Dermatology

Mechanisms of metastasis

TH Nguyen

CLINICS IN DERMATOLOGY (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.